Cih‐En Huang

727 total citations
45 papers, 452 citations indexed

About

Cih‐En Huang is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Cih‐En Huang has authored 45 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 16 papers in Genetics and 15 papers in Surgery. Recurrent topics in Cih‐En Huang's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (10 papers) and Platelet Disorders and Treatments (6 papers). Cih‐En Huang is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (10 papers) and Platelet Disorders and Treatments (6 papers). Cih‐En Huang collaborates with scholars based in Taiwan, United States and Canada. Cih‐En Huang's co-authors include Chih‐Cheng Chen, Kuan‐Der Lee, Chang Lu, Chang-Hsien Lu, Jrhau Lung, Min-Chi Chen, Feng‐Che Kuan, Miao-Fen Chen, Chang‐Hsien Lu and Yudong Chen and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Cih‐En Huang

42 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cih‐En Huang Taiwan 14 130 121 112 96 95 45 452
Prashanth Giridhar India 11 96 0.7× 137 1.1× 52 0.5× 191 2.0× 74 0.8× 43 507
R. Jyothirmayi United Kingdom 13 124 1.0× 142 1.2× 79 0.7× 120 1.3× 67 0.7× 30 485
P. Foa Italy 13 149 1.1× 138 1.1× 181 1.6× 244 2.5× 65 0.7× 26 507
Romeo A. Mandanas United States 10 226 1.7× 102 0.8× 166 1.5× 93 1.0× 39 0.4× 21 459
Hua‐Ling Tsai United States 11 108 0.8× 97 0.8× 176 1.6× 140 1.5× 25 0.3× 44 494
Tanja Pelz Germany 10 92 0.7× 152 1.3× 44 0.4× 157 1.6× 36 0.4× 16 562
Loredana Costa Italy 11 124 1.0× 202 1.7× 64 0.6× 176 1.8× 69 0.7× 29 496
Chandrika N. Nair India 13 117 0.9× 191 1.6× 107 1.0× 94 1.0× 89 0.9× 34 435
T Pick United States 13 86 0.7× 137 1.1× 71 0.6× 162 1.7× 113 1.2× 21 523
T. Girinsky France 12 99 0.8× 90 0.7× 182 1.6× 250 2.6× 59 0.6× 22 574

Countries citing papers authored by Cih‐En Huang

Since Specialization
Citations

This map shows the geographic impact of Cih‐En Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cih‐En Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cih‐En Huang more than expected).

Fields of papers citing papers by Cih‐En Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cih‐En Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cih‐En Huang. The network helps show where Cih‐En Huang may publish in the future.

Co-authorship network of co-authors of Cih‐En Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Cih‐En Huang. A scholar is included among the top collaborators of Cih‐En Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cih‐En Huang. Cih‐En Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chih‐Cheng, et al.. (2024). Treatment outcome and germline predictive factors of ropeginterferon alpha‐2b in myeloproliferative neoplasm patients. Cancer Medicine. 13(7). e7166–e7166. 1 indexed citations
2.
Lheureux, Stéphanie, Han Han, Lee S. Rosen, et al.. (2024). 631P Phase Ib expansion study of CX-5461 in patients with solid tumours and BRCA2 and/or PALB2 mutation. Annals of Oncology. 35. S503–S503. 1 indexed citations
3.
4.
Huang, Cih‐En, Yi‐Yang Chen, Yuying Wu, et al.. (2023). THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023030–e2023030. 2 indexed citations
5.
Chen, Ying‐Ju, Ming‐Chung Wang, Yi‐Yang Chen, et al.. (2023). Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR-Mutated MPN. International Journal of Molecular Sciences. 24(10). 8747–8747.
6.
Lin, Wei‐Yu, Meng‐Hung Lin, Yao‐Hsu Yang, et al.. (2022). Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma. Frontiers in Surgery. 9. 903123–903123. 1 indexed citations
7.
Huang, Cih‐En, Yuying Wu, Wei‐Ming Chen, et al.. (2021). Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. Biomedical Journal. 45(5). 788–797. 10 indexed citations
8.
Chien, Sheng‐Hsuan, Ming Yao, Chi-Cheng Li, et al.. (2021). Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Journal of the Formosan Medical Association. 120(12). 2144–2152. 7 indexed citations
9.
Huang, Cih‐En, Yuying Wu, Chia‐Chen Hsu, et al.. (2020). Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms. Journal of the Formosan Medical Association. 120(2). 863–873. 13 indexed citations
10.
Chen, Chih‐Cheng, Jrhau Lung, Cih‐En Huang, et al.. (2017). Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2 -mutated myeloproliferative neoplasms. Haematologica. 102(3). 509–518. 14 indexed citations
11.
Cheng, Chun-Yu, Chia‐Yu Hsu, Yuan‐Hsiung Tsai, et al.. (2017). Novel Anterior Brainstem Magnetic Resonance Imaging Findings in Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis. Frontiers in Neurology. 8. 579–579. 8 indexed citations
12.
Chen, Chien‐Min, et al.. (2015). The impact of joint range of motion limitations on health‐related quality of life in patients with haemophilia A: a prospective study. Haemophilia. 21(3). e176–e184. 22 indexed citations
13.
Chen, Chih‐Cheng, et al.. (2015). Favorable clinical outcome and unique characteristics in association with Twist1 overexpression in de novo acute myeloid leukemia. Blood Cancer Journal. 5(8). e339–e339. 15 indexed citations
14.
Huang, Cih‐En, et al.. (2015). Clinical efficacy and safety of ruxolitinib in the management of myelofibrosis: A single institution experience in Taiwan. Hematology. 21(1). 3–9. 4 indexed citations
15.
Chen, Chih‐Cheng, et al.. (2014). Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia. Annals of Hematology. 93(12). 2029–2036. 41 indexed citations
16.
Lu, Chang, et al.. (2014). Clinical Characteristics and Treatment Outcome in a Taiwanese Population of Patients with Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma. Japanese Journal of Clinical Oncology. 44(12). 1164–1171. 13 indexed citations
17.
Lu, Chang-Hsien, Kuan‐Der Lee, Chih‐Cheng Chen, et al.. (2013). Second primary malignancies following thyroid cancer: a population-based study in Taiwan. European Journal of Endocrinology. 169(5). 577–585. 40 indexed citations
18.
Huang, Cih‐En, et al.. (2011). Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer. Journal of Clinical Pharmacy and Therapeutics. 37(3). 342–347. 11 indexed citations
19.
20.
Yang, Cheng‐Ta, et al.. (2010). Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. Journal of Cancer Research and Clinical Oncology. 137(1). 115–123. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prashanth Giridhar Breakdown of academic impact, for papers by R. Jyothirmayi Breakdown of academic impact, for papers by P. Foa Breakdown of academic impact, for papers by Romeo A. Mandanas Breakdown of academic impact, for papers by Hua‐Ling Tsai Breakdown of academic impact, for papers by Tanja Pelz Breakdown of academic impact, for papers by Loredana Costa Breakdown of academic impact, for papers by Chandrika N. Nair Breakdown of academic impact, for papers by T Pick Breakdown of academic impact, for papers by T. Girinsky
Rankless by CCL
2026